What is it about?

The coronavirus disease 2019 (COVID-19) pandemic has disrupted clinical care. We examined whether and observed the COVID-19 pandemic was associated with within-individual delays in glycated hemoglobin testing, retinal screening, and nephropathy evaluations.

Featured Image

Read the Original

This page is a summary of: Impact of the COVID-19 Pandemic on Diabetes Care Among a North Carolina Patient Population, Clinical Diabetes, October 2022, American Diabetes Association,
DOI: 10.2337/cd21-0136.
You can read the full text:

Read

Contributors

Be the first to contribute to this page